Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Trial to Assess the Impact of Home Monitoring to Decrease the Treatment Burden for Neovascular Macular Degeneration (the LIBERTY Study).

NCT01863199 is registered in ClinicalTrials.gov with Retinal Consultants of Arizona as lead sponsor.

NCT NCT01863199
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01863199 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Trial to Assess the Impact of Home Monitoring to Decrease the Treatment Burden for Neovascular Macular Degeneration (the LIBERTY Study).
Lead sponsor
Retinal Consultants of Arizona
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2013
Completion date
December 31, 2015
Enrollment
60 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

neovascular age related macular degeneration